Linrui Gao

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Medical University Cancer Institute and Hospital · ORCID：0000-0003-2730-7910

发表论文 44 篇 · 总被引 302 次 · h-index 10

代表论文

• Minimal residual disease profiling predicts pathological complete response in esophageal squamous cell carcinoma (2024 · Molecular Cancer · 被引 21)
• Tumor-Derived Exosomal miR-143-3p Induces Macrophage M2 Polarization to Cause Radiation Resistance in Locally Advanced Esophageal Squamous Cell Carcinoma (2024 · International Journal of Molecular Sciences · 被引 13)
• Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapy (2022 · Therapeutic Advances in Medical Oncology · 被引 11)
• Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac (2023 · Frontiers in Oncology · 被引 8)
• A patient-specific auto-planning method for MRI-guided adaptive radiotherapy in prostate cancer (2024 · Radiotherapy and Oncology · 被引 5)
• Multicenter Phase Ii Study of Moderate Low-Dose Radiotherapy in Indolent Non-Hodgkin Lymphoma: CLCG-iNHL-01 Protocol (2024 · Future Oncology · 被引 5)